• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎即时检测——可行性、参与者知识及结果评估

Rapid point-of-care testing for hepatitis C - assessment of feasibility, knowledge of participants and outcomes.

作者信息

Khan Afrasyab, Tarr Anna, Berahmana Arvenia Boyke, Johnson Eric, Schultz Michael, Johnson Steven

机构信息

Department of Medicine, University of Otago, Dunedin, New Zealand.

出版信息

Gastroenterol Hepatol Bed Bench. 2024;17(3):260-269. doi: 10.22037/ghfbb.v17i3.2989.

DOI:10.22037/ghfbb.v17i3.2989
PMID:39308536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11413387/
Abstract

AIM

We assessed the feasibility of point-of-care testing to gain insights into participants' knowledge, experience and its effect on hepatitis C management.

BACKGROUND

In New Zealand, only 50% of people infected with hepatitis C (HCV) are currently diagnosed. HCV infection is the most common diagnosis leading to liver transplantation in New Zealand. A point-of-care test can streamline HCV management.

METHODS

The OraQuick HCV test (mouth swab or finger-prick) was offered to participants aged 45 to 65 and anyone with a risk factor for hepatitis C. Data collected included demographics, risk factors, and participant experience with testing.

RESULTS

A total of 218 participants were recruited. The median age was 29 years (IQR 22 to 46). All the tests via the finger-prick method were negative. Fourteen positive mouth-swab tests were negative on ELISA testing. One person was detected to have HCV infection and treated. Knowledge regarding HCV was low. There were no statistically significant differences in knowledge between participants with different education levels, F (4213=0.857, P=0.491 and different ethnicities, F (4,213)0.857, P=0.491. The majority of study participants preferred the point-of-care test.

CONCLUSION

Point-of-care testing for HCV is feasible and preferred. Knowledge regarding HCV was low. This study has also provided valuable insights into the viability and experience of offering point-of-care testing.

摘要

目的

我们评估了即时检测对于深入了解参与者的知识、经验及其对丙型肝炎管理的影响的可行性。

背景

在新西兰,目前只有50%的丙型肝炎(HCV)感染者被诊断出来。HCV感染是新西兰导致肝移植的最常见诊断原因。即时检测可以简化HCV管理。

方法

向45至65岁的参与者以及任何有丙型肝炎危险因素的人提供OraQuick HCV检测(口腔拭子或手指采血)。收集的数据包括人口统计学信息、危险因素以及参与者的检测经验。

结果

共招募了218名参与者。中位年龄为29岁(四分位间距为22至46岁)。所有通过手指采血方法进行的检测均为阴性。14次口腔拭子检测呈阳性,但酶联免疫吸附测定检测为阴性。检测出1人感染HCV并接受了治疗。关于HCV的知识水平较低。不同教育水平的参与者之间在知识方面没有统计学上的显著差异,F(4,213)=0.857,P=0.491;不同种族的参与者之间也没有显著差异,F(4,213)=0.857,P=0.491。大多数研究参与者更喜欢即时检测。

结论

HCV即时检测是可行的且更受青睐。关于HCV的知识水平较低。本研究还为提供即时检测的可行性和经验提供了有价值的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f71c/11413387/ea00b6bdb232/GHFBB-17-260-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f71c/11413387/9af401917543/GHFBB-17-260-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f71c/11413387/ea00b6bdb232/GHFBB-17-260-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f71c/11413387/9af401917543/GHFBB-17-260-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f71c/11413387/ea00b6bdb232/GHFBB-17-260-g002.jpg

相似文献

1
Rapid point-of-care testing for hepatitis C - assessment of feasibility, knowledge of participants and outcomes.丙型肝炎即时检测——可行性、参与者知识及结果评估
Gastroenterol Hepatol Bed Bench. 2024;17(3):260-269. doi: 10.22037/ghfbb.v17i3.2989.
2
Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.分散式与集中式药物替代方案中丙型肝炎的管理以及用于弥合丙型肝炎病毒治疗流程差距的微创即时检测
Swiss Med Wkly. 2017 Nov 20;147:w14544. doi: 10.4414/smw.2017.14544. eCollection 2017.
3
Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study.从针具和注射器项目进行即时丙肝检测:澳大利亚可行性研究。
Int J Drug Policy. 2019 Oct;72:91-98. doi: 10.1016/j.drugpo.2019.05.012. Epub 2019 May 22.
4
Point-of-care rapid testing for hepatitis C antibodies at New Zealand needle exchanges.新西兰针头交换处的丙型肝炎抗体即时快速检测
N Z Med J. 2020 Nov 20;133(1525):84-95.
5
Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department.澳大利亚市中心急诊部门即时检测丙型肝炎病毒和与治疗的衔接
Int J Drug Policy. 2019 Oct;72:84-90. doi: 10.1016/j.drugpo.2019.06.021. Epub 2019 Jul 24.
6
Reducing Read Time of Point-of-Care Test Does Not Affect Detection of Hepatitis C Virus and Reduces Need for Reflex RNA.降低即时检验读片时间并不影响丙型肝炎病毒检测,且减少了对 RNA 反射检测的需求。
Clin Gastroenterol Hepatol. 2021 Jul;19(7):1451-1458.e4. doi: 10.1016/j.cgh.2020.07.058. Epub 2020 Aug 4.
7
Evaluation of a new point-of-care oral anti-HCV test for screening of hepatitis C virus infection.评价一种新的即时口腔抗 HCV 检测用于 HCV 感染的筛查。
Virol J. 2020 Jan 31;17(1):14. doi: 10.1186/s12985-020-1293-7.
8
Feasibility and Acceptability of Antenatal Hepatitis C Screening: A Pilot Study.产前丙型肝炎筛查的可行性和可接受性:一项试点研究。
Can J Gastroenterol Hepatol. 2024 Aug 27;2024:7696410. doi: 10.1155/2024/7696410. eCollection 2024.
9
Outcomes of the CT2 study: A 'one-stop-shop' for community-based hepatitis C testing and treatment in Yangon, Myanmar.CT2 研究结果:缅甸仰光基于社区的丙型肝炎检测和治疗的“一站式服务”。
Liver Int. 2021 Nov;41(11):2578-2589. doi: 10.1111/liv.14983. Epub 2021 Jul 10.
10
Validation of hepatitis C virus RNA detection using capillary blood by finger prick (GenXpert system)-Hepatitis C fingerprick study.经指尖采血(GeneXpert 系统)检测丙型肝炎病毒 RNA 的验证——丙型肝炎指尖采血研究。
J Viral Hepat. 2020 Jul;27(7):709-714. doi: 10.1111/jvh.13284. Epub 2020 Mar 13.

本文引用的文献

1
Turning the Tide on Hepatitis C Virus-Related Liver Transplantation: The Return on Investment in Hepatitis C Virus Treatment in Australia and New Zealand.扭转丙型肝炎病毒相关肝移植的局面:澳大利亚和新西兰丙型肝炎病毒治疗的投资回报。
Liver Transpl. 2022 Feb;28(2):236-246. doi: 10.1002/lt.26329. Epub 2021 Nov 10.
2
Barriers and facilitators to hepatitis C (HCV) screening and treatment-a description of prisoners' perspective.阻碍和促进丙型肝炎(HCV)筛查和治疗的因素——囚犯视角的描述。
Harm Reduct J. 2018 Dec 11;15(1):62. doi: 10.1186/s12954-018-0269-z.
3
Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia.
澳大利亚注射吸毒人群中即时指尖全血和静脉采血丙型肝炎病毒检测的可接受性和偏好。
Int J Drug Policy. 2018 Nov;61:23-30. doi: 10.1016/j.drugpo.2018.08.011. Epub 2018 Oct 25.
4
A liver health hui: hepatitis C knowledge and associated risk factors in New Zealand gang members and their families.一场肝脏健康研讨会:新西兰帮派成员及其家人的丙型肝炎知识及相关风险因素
R Soc Open Sci. 2018 Aug 29;5(8):172167. doi: 10.1098/rsos.172167. eCollection 2018 Aug.
5
Patient and provider perspectives inform an intervention to improve linkage to care for HIV patients in Ukraine.患者和医疗服务提供者的观点为一项旨在改善乌克兰艾滋病毒患者与医疗服务联系的干预措施提供了依据。
BMC Health Serv Res. 2018 Jan 30;18(1):58. doi: 10.1186/s12913-018-2885-4.
6
Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis.丙型肝炎即时诊断:寻找单次就诊的诊断方法。
Expert Rev Mol Diagn. 2017 Dec;17(12):1109-1115. doi: 10.1080/14737159.2017.1400385. Epub 2017 Nov 8.
7
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.1980 - 2015年全球、区域和国家249种死因的预期寿命、全死因死亡率和死因别死亡率:全球疾病负担研究2015的系统分析
Lancet. 2016 Oct 8;388(10053):1459-1544. doi: 10.1016/S0140-6736(16)31012-1.
8
Liver transplantation in Australia and New Zealand.澳大利亚和新西兰的肝移植
Liver Transpl. 2016 Jun;22(6):830-8. doi: 10.1002/lt.24446.
9
Public health clinic-based hepatitis C testing and linkage to care in Baltimore.巴尔的摩基于公共卫生诊所的丙型肝炎检测及与治疗的衔接
J Viral Hepat. 2016 May;23(5):366-74. doi: 10.1111/jvh.12507. Epub 2016 Feb 3.
10
Natural History of Hepatitis C.丙型肝炎的自然史
Gastroenterol Clin North Am. 2015 Dec;44(4):717-34. doi: 10.1016/j.gtc.2015.07.003. Epub 2015 Aug 25.